Fluid Management & Visualization Systems Market Worth $12.5 Billion By 2027

The global fluid management and visualization systems market size is expected to reach USD 12.5 billion by 2027, according to a new report by Grand View Research, Inc., expanding at a CAGR of 5.1% from 2020 to 2027.

The fluid management and visualization systems significantly enhance procedural effectiveness. Postoperative and perioperative fluid management has a significant impact on patient outcomes and plays a pivotal role in enhanced recovery pathways (ERPs). Moreover, fluid management and visualization leads to a decrease in complications and a decrease in length of stay (LOS). Thus, preoperative and postoperative fluid management and visualization is as critical as intraoperative management as it offers multiple associated benefits to the patients.

Increase in the minimally invasive and ambulatory procedures involving large volumes of liquids adds stress and inefficiency in the OR. This, in turn, facilitates the adoption of fluid management and visualization systems in the medical settings. According to the study by researchers at the University of Michigan, January 2020, the use of robotic surgery for all general surgery procedures increased from 1.8% in 2012 to 15.1% in 2018.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/fluid-management-visualization-systems-market

Further key findings from the report suggest:

North America accounted for the largest revenue share in 2019 owing to well-established healthcare infrastructure, significant investment by market players for novel product development, and increasing prevalence of gynecology, urology, and cardiac conditions
By product, the accessories segment dominated the market in 2019 as these products need to be disposed after single use, thus preventing infections and assuring patient safety
In terms of application, the urology segment dominated the market in 2019 due to increasing cases of kidney stones and prostate and bladder problems
Based on end use, the hospitals segment accounted for the largest market share in 2019 as they conduct larger number of surgical procedures with the availability of novel automated fluid management and visualization systems
Market players are adopting several strategies such as significant investment in research and development, product innovation via acquisitions and collaborations, and geographical expansion in developing countries to gain a significant share in the global market.

North America, Europe & Asia Pacific Legal Cannabis Market Worth $67.7 Billion By 2026

The North America, Europe, and Asia Pacific legal cannabis market size is anticipated to reach USD 67.7 billion by 2026, registering a CAGR of 19.6% during the forecast period, according to a new report by Grand View Research, Inc. The increased adoption of hemp and marijuana products coupled with the rising demand for medical marijuana is anticipated to drive the market growth. Furthermore, the impending legalization of marijuana for adult use is an important factor supporting the growth over the forecast period.

Based on product type, marijuana dominated the market with a revenue share of USD 96.6% in 2019. The use of marijuana for medical purposes is gaining momentum owing to recent legalizations in various countries. Marijuana is used for the treatment of patients with chronic conditions such as Parkinson’s disease, cancer, arthritis, Alzheimer’s disease, neurologic problems like depression, anxiety, epilepsy, and others. Thus, wide application of marijuana for the treatment of various chronic conditions is one of the major factors driving the growth of this segment.

Based on application, medical use segment dominated the market with the revenue share of 66.0% in 2019. The medical use of cannabis is legal in a greater number of countries as compared to adult-use, owing to which the segment is expected to remain dominant throughout the forecast period. On the other hand, B2B channels segment is expected to witness the fastest CAGR over the forecast period. The growing use of cannabis and its derivates in various applications areas such as pharmaceuticals, nutraceuticals, personal care and cosmetics, and edibles, is anticipated to boost the demand for these products.

North America dominated the market in 2019 with a revenue share of 91.0%. The early legalization of marijuana for medical and adult-use and the presence of a large customer pool in the region are the key factors driving the market growth. On the other hand, Asia Pacific is expected to be the fastest-growing region, owing to rising awareness regarding the medical and health benefits of cannabis, encouraging the Asian countries to legalize cannabis and its derivatives.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/north-america-europe-asia-pacific-legal-cannabis-market

Further key findings from the study suggest:

Marijuana emerged as leading product segment in 2019 with a revenue share of 96.6%, owing to the growing adoption of marijuana for various medical conditions
B2B channel is anticipated to be the fastest-growing application segment, owing to the increasing use of cannabinoids for a wide range of industries
North America accounted for the largest share, owing to the higher consumption rate due to legal acceptance of cannabis
Some of the key players include Aphria, Inc.; Canopy Growth Corporation, Aurora Cannabis, Maricann Group, Inc.; ABcann Medicinals, Inc.; Tilray, The Cronos Group, GW Pharmaceuticals, plc., Organigram Holding, Inc.; and Lexaria Bioscience Corp

Insulin Storage Devices Market Size Worth $1.3 Billion By 2027

The global insulin storage devices market size is expected to reach USD 1.3 billion by 2027, registering revenue based CAGR of 7.8% over the forecast period, according to a new report by Grand View Research, Inc. Increasing incidence of diabetes and rising adoption of advanced insulin delivery devices are the key factors driving the market. Rising government initiatives and increasing awareness about insulin storage are also among the major factors contributing to the market growth.

A sedentary lifestyle and nutrition transition are some of the major factors leading to increasing cases of obesity, which significantly enhances the risk of diabetes. According to the WHO, in 2016, there were 650 million obese people in the world and this number is expected to rise significantly during the forecast period. Diabetes-related healthcare expenditure, both public and private, is also expected to grow rapidly. According to the International Diabetes Federation, healthcare expenditure due to diabetes is expected to reach 214 billion by 2045. With the increase in diabetes-related healthcare expenditure, the insulin storage devices market is expected to see frequent new product launches and advanced delivery devices thus, boosting the demand for advanced insulin storage solutions.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/insulin-storage-devices-market

Further key findings from the report suggest:

North America accounted for the largest insulin storage devices market share in 2019 owing to favorable reimbursement policies, presence of key players, and frequent product launches
Asia Pacific is expected to see robust growth during the forecast period owing to the large diabetic population
By product, the battery-operated devices segment dominated the market owing to high cost of products and high adoption
The type 1 patients segment accounted for the largest revenue share/ volume share due to high demand, whereas the type 2 patients segment is expected to grow at the fastest rate due to rising awareness about diabetes preventive care
The leading players in the industries are DISIONCARE; ReadyCare, LLC; Tawa Outdoor; Medicool, Arkray, Inc.; Cooluli; Zhengzhou Defrigus Electric Device Co. Ltd.; Zhengzhou Olive Electronic Technology Co., Ltd.; and others.

Cannabidiol Nutraceuticals Market Size Worth $17.4 Billion By 2026

The global CBD nutraceuticals market is projected to reach USD 17.4 billion by 2026, according to a new report by Grand View Research, Inc. It is anticipated to exhibit a CAGR of 18.8% during the forecast period. Introduction of the 2018 Farm Bill that legalized hemp cultivation and hemp-derived products in U.S., rising consumer preference for plant-based ingredients in dietary supplements, and awareness regarding the health benefits of cannabidiol are some of the factors powering the market growth. However, the easy availability of alternative products is obstructing market growth.

CBD tinctures dominated the global Cannabidiol (CBD) nutraceuticals market in 2018, with a revenue share of 42.6%. Increasing acceptance of cannabidiol for health and wellness purposes coupled with high bioavailability of tinctures when administered sublingually are the major factors responsible for this large market share. On the other hand, capsules and soft gels are anticipated to be the fastest-growing product type over the forecast period, as they are travel-friendly and convenient to carry in public places. However, many consumers dislike the raw taste and texture of cannabidiol and so they are switching towards capsules and softgels.

Based on the sales channel, retail store segment dominated the CBD (Cannabidiol) nutraceuticals market in 2018, as consumers prefer retail stores for buying dietary supplements due to attractive pricing. On the other hand, the online sales channel is expected to expand at the fastest CAGR over the forecast period owing to the rise in the preference for online shopping. Furthermore, the new entrants in the CBD nutraceuticals space, find online sales channel a much economical alternative than a retail storefront.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/cbd-nutraceuticals-market

Further key findings from the report suggest:

In 2018, CBD tinctures dominated the Cannabidiol nutraceuticals market with a revenue share of 42.6%, due to the higher bioavailability than other product types
The online sales channel is projected to witness the fastest growth rate over the forecast period. Many companies are opting for this channel, as it is a faster way to reach the target audience
Some of the major market players are Medical Marijuana Inc.; CV Sciences Inc.; CHARLOTTE’S WEB; Irwin Naturals; and MGC Pharma

Aerospace & Defense Materials Market Worth $28.37 Billion By 2027

The global aerospace and defense materials market size is expected to reach USD 28.37 billion by 2027, registering a revenue-based CAGR of 4.0% during the forecast period, according to a new report published by Grand View Research, Inc. Increasing investment in modernization along with expansion of combat aircraft fleet in countries, such as India and China is expected to drive the growth.

The market is expected to benefit from the strong demand for aircraft in the foreseeable future. The number of commercial and cargo fleets around the world is expected to double over the forecast period. The huge surge in passenger and freight traffic is also anticipated to contribute significantly to the increase in aircraft production and demand for aerospace & defense materials.

The aerospace & defense industry has been a long-term promoting factor for the development and application of advanced materials. Leading manufacturers are increasingly adopting a variety of advance materials such as carbon fiber composites and titanium alloys. These materials play an important role in reducing the overall weight and increasing fuel efficiency of an aircraft.

The market players often enter into long-term supply contracts with aircraft manufacturers. The material manufacturers provide highly customized solutions to the component and aircraft manufacturer. Aircraft manufacturers are often involved in monitoring the materials throughout the value chain from design to component manufacturing to ensure the quality.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/aerospace-defense-materials-market

Further key findings from the report suggest:

Composites is expected to register the highest CAGR of 3.8% in terms of revenue, from 2020 to 2027, owing to the lightweight, high strength, and impact resistance characteristics of the product
Aerostructure is estimated to be the largest application segment. It accounted for a revenue of USD 10.37 billion in 2019. However, the segment is expected witness a decline in volume due to increased substitution of metals with composites
Commercial aircraft is estimated to witness substantial growth in terms of revenue at a CAGR of 4.1% from 2020 to 2027, owing to increasing demand from developing economies
North America held the largest revenue share of the aerospace and defense materials market with 1.8% in 2019, owing to the presence of huge aircraft parts manufacturing industry in the region
Major market players focus on mergers and acquisitions to expand their business and technological capabilities. They prioritize R&D of low cost materials that provide high strength

Ice Hockey Equipment Market Worth $1.1 Billion By 2025

The global ice hockey equipment market size is expected to reach USD 1.1 billion by 2025, according to a new report by Grand View Research, Inc., expanding at a CAGR of 3.2% over the forecast period. The market is expected to witness significant growth due to increase in participation rate, which is attributed to rise in availability of synthetic ice rinks.

Protective wear occupied the largest market share in 2018 owing to the nature of the sport. Serious injuries such as head concussions, shoulder separation, and ankle sprains are common in this sport. According to an article published in the British Journal of Sports Medicine, 39.8% of the injuries were related to head and face. As a result, CCM, one of the key manufacturers of ice hockey equipment, launched the Resistance Helmet, which is considered to be one of the most innovative ice hockey helmets in Canada. Similar product launches to improve the safety are anticipated to contribute to the growth of the market during the forecast period.

Offline sales accounted for the largest market share in 2018. Players prefer to check the quality and specifications of the equipment before completing the purchase. Leveraging this preference, Pure Hockey, one of the largest hockey retailers in U.S. acquired Bauer Hockey’s “Own the Moment” retail stores. With this acquisition, Pure Hockey now operates in 53 locations across U.S.

Such sports specialty stores are anticipated to generate offline sales during the forecast period. Growth of the e-commerce industry is expected to drive online sales with a CAGR of 4.2%. Customer reviews, secure payment transactions, doorstep delivery, and suitable return policies are some of the features driving online sales.

North America held the largest market share in 2018 as ice hockey is the national sport in Canada. The sport is also very popular in U.S., which accounted for the second largest share in the global ice hockey equipment market. Moreover, presence of key players of the industry is concentrated in this region, which is anticipated to drive sales during the forecast period.

Rest of the world is anticipated to witness the fastest growth in this market. Major attributes contributing to the growth are increasing popularity of ice hockey owing to various initiatives taken by the International Ice Hockey Federation (IIHF). In 2019, 12 Asian countries are being represented in the IIHF World Championship program. The CIS region is also anticipated to witness substantial growth on account of increasing participation in countries like Russia and Belarus.

In April 2013, Bauer launched BAUER OD1N product line that included innovative hockey skate, a fully personalized protective body suit, and an ultra-lightweight, customized goal pad constructed with unique materials, which were not previously used in the construction. This product line was aimed at expanding the product portfolio and improving the company’s performance in the market

Click the link below:
https://www.grandviewresearch.com/industry-analysis/ice-hockey-equipment-market

Further key findings from the study suggest:

By product type, the sticks segment is expected to ascend at a CAGR of 3.4% owing to the short shelf life of ice hockey sticks and frequency of play
The global ice hockey equipment market is highly concentrated with a few players such as Bauer, CCM, Easton, and Sher-Wood
In 2017, Adidas sold its CCM hockey business segment to Birch Hill Equity Partners due to decrease in market share of CCM.

Powder Coatings Market Size Worth $19.9 Billion By 2027

The global powder coatings market size is expected to reach USD 19.9 billion by 2027, at a revenue-based CAGR of 7.0% from 2020 to 2027, according to a report by Grand View Research, Inc. The market is expected to witness significant growth over the forecast period primarily owing to superior properties of powder coatings over conventional paints including high resistance to corrosion, chipping, and abrasion, durability, cost-effectiveness, excellent finishing, and reduced processing time.

Growing purchasing power, high living standard, and rapid urbanization is expected to drive the consumer goods sector, thereby driving product demand over the forecast period. Powder coatings are used in consumer goods such as refrigerators, washer tops and lids, air-conditioner cabinets, water heaters, range housings, dishwashers, microwave oven cavities, and freezer cabinets.

Asia Pacific emerged as the fastest-growing region and is expected to witness a CAGR of 7.8%, in terms of revenue, over the forecast period. Increasing demand for consumer goods such as washing machines and refrigerators in countries such as India, China, Vietnam, Philippines, and Thailand are expected to boost demand for powder coating in these applications. Growing demand for automobiles in emerging markets such as China and India coupled with favorable FDI norms by governments is expected to facilitate investment in the region.

North America was the third-largest market and held a market share of 21.9%, in terms of revenue, in 2019. Expanding automotive industry in U.S. and rising concerns regarding VOC emissions released from the coatings used in automobile production are expected to boost the demand for powder coatings in the region.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/powder-coatings-market-analysis

Further key findings from the report suggest:

Epoxy-Polyester (Hybrid) is expected to be the fastest growing resin type during the forecast period from 2020 to 2027
Consumer goods application occupied the largest revenue share on account of rising demand for domestic appliances in emerging countries such as India, China, Vietnam, Philippines, and Thailand. This, in turn, is expected to boost the demand for powder coatings in the coming years
Major key players in powder coatings market includes Akzo Nobel N.V; The Sherwin-Williams Company; PPG Industries, Inc.; BASF SE; DSM; Valspar; Axalta Coating Systems; Arkema S.A.; and Bayer AG.

Europe Hydrocarbon Solvent Market Size Worth $1.93 Billion By 2025

The Europe hydrocarbon solvent market size is expected to reach USD 1.93 billion by 2025, according to a new report by Grand View Research, Inc. it is anticipated to expand at a CAGR of 5.1% during the forecast period. Abundant availability of key petrochemical raw materials, relatively lower price of petroleum derived solvents compared to their counterparts, and sustained utilization in numerous end-use industries are some of the primary driving factors for the market.

The demand for solvent-based paint and coatings is growing at a steady rate owing to an increase in consumption in architectural applications and end-user industries such as oil and gas, aerospace, marine, and steel. The demand for paints and coatings is also on the rise due to increasing disposable income of consumers, product innovation, and market penetration.

In the European paint industry, white spirit holds a major share, with approximately 60% of this product being used for manufacturing varnishes, paints, and lacquers. Several other products have been introduced in the European market aligned with the regulatory compliances. A number of companies have introduced cycloparaffinic or naphthenic solvents as direct alternatives to xylene and toluene, which are aromatic but strictly regulated owing to their high Volatile Organic Compound (VOC) content.

One of the most significant value addition in the manufacturing of the hydrocarbon solvents is the commercialization of products with minimal or negligible environmental impact. The solvents with least VOCs proportions are gaining traction. Such trends are anticipated to significantly contribute towards rapid demand as well as product innovation by major participants in the Europe hydrocarbon solvent market.

The white spirits is estimated to be the fastest growing product segment with a CAGR of 2.2% in terms of consumption over the forecast period. While, aromatic hydrocarbon solvents was the most consumed product category and is expected to generate a total demand of around 910 kilo tons by 2025.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/europe-hydrocarbon-solvents-market

Further key findings from the report suggest:

Paints and coatings was the largest application segment and is expected to be reach over USD 630 million by 2025
Printing inks is one of the fastest growing application categories in Europe hydrocarbon solvents market and is expected to expand at a CAGR of 5.3% in terms of value over the next seven years
Germany accounted for over 15% of the total regional demand and is estimated to generated a total revenue of USD 316.9 million by 2025
Companies are now concentrating on sustainable approaches to manufacture chemical intermediates with very low VOC content to prevent serious environmental impact
Some of the key players operating in the Europe hydrocarbon solvent market include Eastman Chemical Corporation, Dow Dupont, BASF SE, Total SA, Ashland, and Chevron Corporation.

Medical Marijuana Market Size To Reach USD 55.8 Billion By 2025

The global medical marijuana market is expected to reach a value of USD 55.8 billion by 2025, according to a new report by Grand View Research, Inc. It has been identified that, in 2016, Washington D.C. along with 28 states have legalized marijuana for medical uses. In 2016, states such as Arkansas, Florida, North Dakota, Ohio, and Pennsylvania were approved to use the drug in medical applications such as chemotherapies and pain management. The growing number of states and countries getting approval for using it in therapeutic applications is one of the crucial factors driving the demand over the coming few years.

The presence of several regulatory frameworks such as the Medical Marijuana Regulation and Safety Act is indicators of the present demand for the drug in the market. The regulatory framework requires every individual or the company associated such as growers, retail operators, and makers of processed pot products to obtain permission and an annual state license from 2018. An increasing number of issued licenses is also among factors that is expected to drive the market especially after 2018.

The increasing interest amongst the academic researchers and healthcare providers regarding the therapeutic uses of marijuana is among the significant factors, which is driving the market over the coming years. Some of its potential therapeutic values are suppression of vomiting & nausea, pain relief, and appetite stimulation. In addition, research states that marijuana is effective in providing relief to the patient suffering from HIV/AIDS, glaucoma, cancer, and multiple sclerosis. The growing number of therapeutic applications of the drug is one of the key factors that is propelling the market over the forecast period.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/medical-marijuana-market

Further key findings from the study suggest:

Medical marijuana makes use of the marijuana plant, or the chemicals present in it, for the treatment of diseases or conditions. The chemicals present in marijuana are called cannabinoids, with the delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) being the main chemicals used in medicine. This product can be used in the treatment of widespread conditions such as Alzheimer’s, cancer, epilepsy and glaucoma, among many others
According to ProCon.org, as of May 2018, there were more than 2.1 million legal medical marijuana patients in the United States, with Maine being the leading state with 38.42 marijuana patients per 1000 state residents, while other states such as California (23.16), Arizona (23.16), Michigan (27.06) and Montana (24.49) also have a sizeable population of medical marijuana users. As the norms become more relaxed in the coming years, the market for medical marijuana will spread more rapidly in the country
One of the most effective areas of medical marijuana use is in the treatment of multiple sclerosis. A number of European trials using the THC/CBD combo drug nabiximols (oral cannabis extract) has shown great efficacy in this regard. With multiple sclerosis estimated to affect 1 million people in the US and about 2.5 million people globally, according to the National MS Society, there is a great scope for the global expansion of the product
As of July 2019, the use of recreational cannabis was not legalized in a large number of countries around the globe, with Canada and Uruguay being the only exceptions. However, the effectiveness of medical grade marijuana has been understood by some countries such as Israel, Australia and Germany, who have promptly legalized it. Thailand is the first country in Asia to have completely legalized medical marijuana, with the country also seeing its first medical marijuana clinic open in Bangkok. However, the spread of legalization has generally been slow
Some of the key players are Cara Therapeutics Inc.; CannaGrow Holdings, Inc.; Cannabis Sativa, Inc.; United Cannabis Corporation; GrowBlox Sciences, Inc.; GW Pharmaceuticals, plc; Lexaria Corp; International Consolidated Companies, Inc.